Thomas E. Stinchcombe
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 98
- Lung Cancer Diagnosis and Treatment 92
- Oncology 64
- Cancer Immunotherapy and Biomarkers 27
- Lung Cancer Research Studies 21
- Cancer Treatment and Pharmacology 5
- Co-authors
- Mark A. Socinski (57 shared papers)Patrick J. Roberts (3 shared papers)Carrie B. Lee (16 shared papers)Everett E. Vokes (34 shared papers)Dominic T. Moore (13 shared papers)Vinicius Ernani (1 shared paper)Xiaofei Wang (26 shared papers)Julian G Rosenman (10 shared papers)
- Journals
- Journal of Thoracic Oncology (41 papers)Journal of Clinical Oncology (27 papers)Lung Cancer (14 papers)Clinical Lung Cancer (13 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)
- Partner nations
- United StatesCanadaHong Kong
In The Last Decade
Thomas E. Stinchcombe
227 papers receiving 10k citations
Thomas E. Stinchcombe's Hit Papers
Peers
Comparison fields: 5 of 114
- Pulmonary and Respiratory Medicine 4.7k
- Oncology 2.8k
- Radiation 342
- Cancer Research 407
- Geriatrics and Gerontology 99
Countries citing papers authored by Thomas E. Stinchcombe
This map shows the geographic impact of Thomas E. Stinchcombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Stinchcombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Stinchcombe more than expected).
Fields of papers citing papers by Thomas E. Stinchcombe
This network shows the impact of papers produced by Thomas E. Stinchcombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Stinchcombe. The network helps show where Thomas E. Stinchcombe may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Stinchcombe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 238 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial Hit paper breakdown → | 2015 | 1243 |
| 2 | Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer Hit paper breakdown → | 2023 | 634 |
| 3 | 2002 | 625 | |
| 4 | Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study Hit paper breakdown → | 2017 | 512 |
| 5 | Cardiac Toxicity After Radiotherapy for Stage III Non–Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy Hit paper breakdown → | 2017 | 350 |
| 6 | 2007 | 297 | |
| 7 | Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503) Hit paper breakdown → | 2018 | 279 |
| 8 | 2010 | 211 | |
| 9 | 2013 | 208 | |
| 10 | 2018 | 205 | |
| 11 | 2012 | 196 | |
| 12 | 2019 | 186 | |
| 13 | 2007 | 183 | |
| 14 | 2011 | 162 | |
| 15 | 2013 | 159 | |
| 16 | 2012 | 146 | |
| 17 | 2016 | 134 | |
| 18 | 2019 | 134 | |
| 19 | 2009 | 121 | |
| 20 | 2007 | 105 |
About Thomas E. Stinchcombe
Thomas E. Stinchcombe is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Statistics and Probability, Radiation and Genetics, having authored 238 papers that have together received 10.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (98 papers), Lung Cancer Diagnosis and Treatment (92 papers), Cancer Immunotherapy and Biomarkers (27 papers), Lung Cancer Research Studies (21 papers), Statistical Methods in Clinical Trials (7 papers), Genetic Associations and Epidemiology (6 papers), Ethics in Clinical Research (6 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.7k citations), Oncology (2.8k citations), Radiation (342 citations), Cancer Research (407 citations) and Geriatrics and Gerontology (99 citations). Thomas E. Stinchcombe has collaborated with scholars based in United States, Canada and Hong Kong. Frequent co-authors include Mark A. Socinski, Patrick J. Roberts, Carrie B. Lee, Everett E. Vokes, Dominic T. Moore, Vinicius Ernani, Xiaofei Wang, Julian G Rosenman, Karen L. Kelly and Channing J. Der. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Lung Cancer, Clinical Lung Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.